RedHill Biopharma Ltd RDHL Financial and Strategic SWOT Analysis Review...
SummaryRedHill Biopharma Ltd RedHill is a biopharmaceutical company that develops and commercializes small molecule therapeutics in the areas of gastroenterology oncology and inflammation. The...
View ArticleEvidence supporting infliximab biosimilar use in Crohns
According to GlobalData realworld evidence supporting infliximab biosimilar use in Crohn s disease will boost the market and help patients
View ArticlePhase III IMpower131 Study Showed Genentechs TECENTRIQ Atezolizumab Plus...
Genentech a member of the Roche Group SIX RO ROG; OTCQX RHHBY today announced that the Phase III IMpower131 study met its coprimary endpoint of progressionfree survival PFS and demonstrated that the...
View ArticleTiGenix NV TIG Financial and Strategic SWOT Analysis Review Report Updated...
SummaryTiGenix NV TiGenix is a biopharmaceutical company that develops and commercializes novel therapeutics. Its product portfolio includes AlloCSC01 AlloCSC02 Cx611 and Cx601. The company develops...
View ArticleChemoCentryx Inc CCXI Pharmaceuticals Healthcare Deals and Alliances Profile...
SummaryChemoCentryx Inc ChemoCentryx is a biopharmaceutical company that discovers develops and commercializes orallyadministered therapeutics for the treatment of cancer autoimmune diseases and...
View ArticleOncobiologics Inc ONSIU Financial and Strategic SWOT Analysis Review Report...
SummaryOncobiologics Inc Oncobiologics is a biopharmaceutical company that develops and markets biosimilar therapeutics. The company's product pipeline comprises ONS3010 and ONS1045. It uses...
View ArticleInnate Biologics LLC Enters Into Collaboration Agreement With The Wistar...
Collaboration focused on new approaches to target and treat inflammation at the molecular level Innate Biologics LLC has entered into a collaborative research agreement with The Wistar Institute an...
View ArticleTiGenix NV TIG Pharmaceuticals Healthcare Deals and Alliances Profile Report...
SummaryTiGenix NV TiGenix is a biopharmaceutical company that develops and commercializes novel therapeutics. Its product portfolio includes AlloCSC01 AlloCSC02 Cx611 and Cx601. The company develops...
View ArticleCimzia labeling change addresses concerns for use during pregnancy
The FDA has approved changing the boxed labeling on certolizumab pegol to include data demonstrating a negligibletolow risk for drug transfer through placenta and a minimal risk for transfer through...
View ArticleTiGenix and Takeda announce Alofisel darvadstrocel receives approval to...
PRESS RELEASE REGULATED INFORMATION INSIDE INFORMATION TiGenix and Takeda announce Alofisel darvadstrocel receives approval to treat complex perianal fistulas in Crohn's disease in Europe...
View ArticleTiGenix and Takeda announce Alofisel darvadstrocel receives approval to treat...
PRESS RELEASE REGULATED INFORMATION INSIDE INFORMATION TiGenix and Takeda announce Alofisel darvadstrocel receives approval to treat complex perianal fistulas in Crohn's disease in Europe First ...
View ArticleEMA Committee Backs Remicade Biosimilar Zessly
The committee favors marketing the infliximab biosimilar product Zessly for treatment of rheumatoid arthritis Crohn's disease ulcerative colitis ankylosing spondylitis psoriatic arthritis and...
View ArticleTiGenix and Takeda announce Alofisel darvadstrocel receives...
Alofisel offers a new treatment option for patients who do not respond to current available therapies and may be subject to numerous invasive surgeries1 Leuven Belgium March 23 2018 and Osaka Japan...
View ArticleCoherus BioSciences Inc CHRS Financial and Strategic SWOT Analysis Review...
SummaryCoherus BioSciences Inc Coherus BioSciences formerly known as BioGenerics Inc is a biosimilar platform company that develops and commercializes biosimilar drugs. The company's pipeline product...
View ArticleTaiwanJ Pharmaceuticals Co Ltd 6549 Pharmaceuticals Healthcare Deals and...
SummaryTaiwanJ Pharmaceuticals Co Ltd TaiwanJ is a pharmaceutical company that develops and commercialize firstinclass small molecules as TLR4 antagonists. The company's TLR4 is a transmembrane protein...
View ArticleTakeda and TiGenix's Alofisel becomes first donorderived stem cell therapy...
The European Commission has awarded approval to Takeda and TiGenixs allogeneic expanded adiposederived stem cell eASC therapy Alofisel darvadstrocel for the treatment of complex perianal fistulae in...
View ArticleAevi Genomic Medicine Inc GNMX Financial and Strategic SWOT Analysis Review...
SummaryAevi Genomic Medicine Inc Aevi formerly Medgenics Inc is a research and development company that discovers and develops novel therapies for pediatric onset and lifealtering diseases.The...
View ArticleEU Yes For TiGenix Marks Tenth ATMP Approval in Ten Years
TiGenix says its treatment for complex perianal fistulae in Crohns disease is the first allogeneic stem cell to be approved...&160;&160;&160;
View ArticleTakedas Alofisel becomes Europes first allogenic stem cell therapy
Will treat perianal fistulas in adult patients with Crohn’s disease
View ArticleStem Cell Therapy for Crohns Disease Approved in Europe
Developed by TiGenix AlofiselÂis the first stem cell therapy made out of donor stem cells to receive a marketing authorization in Europe. The European Commission has approved AlofiselÂdarvadstrocel a...
View Article